Abubakar, I;
Lipman, M;
(2019)
Reducing loss to follow up during treatment for drug-resistant tuberculosis.
European Respiratory Journal
, 53
(1)
, Article 1802268. 10.1183/13993003.02268-2018.
Preview |
Text
Lipman_Reducing loss to follow up during treatment for drug-resistant tuberculosis_AAM.pdf - Accepted Version Available under License : See the attached licence file. Download (514kB) | Preview |
Abstract
In this issue of the European Respiratory Journal, Law et al summarise, in their systematic literature review, the evidence for measures that minimise loss to follow-up during treatment of drug-resistant TB in adults. The synthesis of results suggests that supplementing standard care with psychosocial, educational or material support decreased loss to follow-up (defined as treatment interruption of two or more months). The greatest effect was seen when daily home visits were combined with directly observed therapy (DOT).
| Type: | Article |
|---|---|
| Title: | Reducing loss to follow up during treatment for drug-resistant tuberculosis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1183/13993003.02268-2018 |
| Publisher version: | https://doi.org/10.1183/13993003.02268-2018 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10064374 |
Archive Staff Only
 |
View Item |
